Starten Sie Ihre Suche...


Wir weisen darauf hin, dass wir technisch notwendige Cookies verwenden. Weitere Informationen
Publikationen
Ergebnisse pro Seite:  10

Michel, Martin C.; Staskin, David

Study Designs for Evaluation of Combination Treatment: Focus on Individual Patient Benefit

BIOMEDICINES. Bd. 10. H. 2. 2022


Vollert, Jan; Macleod, Malcolm; Dirnagl, Ulrich et al.

The EQIPD framework for rigor in the design, conduct, analysis and documentation of animal experiments

NATURE METHODS. Bd. 19. H. 11. 2022 S. 1334-1337


Xia, Ning; Reifenberg, Gisela; Schirra, Christian et al.

The Involvement of Sirtuin 1 Dysfunction in High-Fat Diet-Induced Vascular Dysfunction in Mice

ANTIOXIDANTS. Bd. 11. H. 3. 2022


Palzer, Kim-Alicia; Bolduan, Vanessa; Kaefer, Rudolf et al.

The Role of KH-Type Splicing Regulatory Protein (KSRP) for Immune Functions and Tumorigenesis

CELLS. Bd. 11. H. 9. 2022


Michel, Martin C.; Heemann, Uwe; de la Rosette, Jean J. M. C. H.

Weak association between arterial hypertension and overactive bladder baseline symptoms and treatment responses

FRONTIERS IN PHARMACOLOGY. Bd. 13. 2022


Muederrisoglu, A. Elif; Oelke, Matthias; Schneider, Tim et al.

What Are Realistic Expectations to Become Free of Overactive Bladder Symptoms? Experience from Non-interventional Studies with Propiverine

ADVANCES IN THERAPY. Bd. 39. H. 6. 2022 S. 2489-2501


Goadsby, Peter J.; Lanteri-Minet, Michel; Michel, Martin C. et al.

21st century headache: mapping new territory

JOURNAL OF HEADACHE AND PAIN. Bd. 22. H. 1. 2021


Alawbathani, Salem; Batool, Mehreen; Fleckhaus, Jan et al.

A teaching tool about the fickle p value and other statistical principles based on real-life data

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY. Bd. 394. H. 6. 2021 S. 1315-1319


Kayki-Mutlu, Gizem; Michel, Martin C.

A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2020

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY. Bd. 394. H. 5. 2021 S. 839-852


Musayeva, Aytan; Jiang, Subao; Ruan, Yue et al.

Aged Mice Devoid of the M-3 Muscarinic Acetylcholine Receptor Develop Mild Dry Eye Disease

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. Bd. 22. H. 11. 2021